Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Amelubant

Generic Name: Amelubant

Drug Type: Small Molecule

Chemical Formula: C_₃₃H_₃₄N_₂O_₅

CAS Number: 346735-24-8

Unique Ingredient Identifier: E0018IF0K4

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and rheumatoid arthritis.

Associated Conditions

No associated conditions information available.

Clinical Trials

Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male Volunteers

Phase 1

Completed

Posted: 2014/10/24

Sponsor:Boehringer Ingelheim

ID:NCT02273440

Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers

Phase 1

Completed

Posted: 2014/10/24

Sponsor:Boehringer Ingelheim

ID:NCT02273427

Study to Evaluate the Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of Prednisone in Healthy Male Subjects

Phase 1

Completed

Posted: 2014/10/20

Sponsor:Boehringer Ingelheim

ID:NCT02268149

Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers

Phase 1

Completed

Posted: 2014/10/16

Sponsor:Boehringer Ingelheim

ID:NCT02265627

Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase 2

Completed

Posted: 2014/09/25

Sponsor:Boehringer Ingelheim

ID:NCT02249338

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy